Mesoblast Ltd. (MESO)

18.94 +0.83 (+4.58%) USD  |  NASDAQ  |  Dec 09, 13:53
More

Mesoblast EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MESO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Telix Pharmaceuticals Ltd. Upgrade
Alterity Therapeutics Ltd. Upgrade
Kazia Therapeutics Ltd. Upgrade
Immutep Ltd. Upgrade
Propanc Biopharma, Inc. Upgrade